PASG

Passage Bio (PASG)

About Passage Bio (PASG)

Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. The company was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Details

Daily high

$5.84

Daily low

$5.54

Price at open

$5.68

52 Week High

$20.00

52 Week Low

$3.94

Market cap

18.3M

Dividend yield

0.00%

Volume

25,235

Avg. volume

41,285

P/E ratio

-.48

Passage Bio News